A 3-Year Review of Frequency and Pattern of Movement Disorders in a Neurologic Clinic of a Tertiary Hospital in Nigeria

Main Article Content

UE Iwuozo
OJ Enyikwola
TP Mbaave
https://orcid.org/0000-0001-7230-4685
OR Obiako

Abstract

Movement disorders are neurological disorders found worldwide with varying forms. They are generally thought to be uncommon in Sub-Saharan Africa because of the relatively large young population. This study evaluated the frequency and pattern of movement disorders in a neurology clinic in a tertiary hospital in North Central Nigeria over a 3-year period. The records of all patients attending Neurology Clinic in Federal Medical Centre, Makurdi, North Central Nigeria were reviewed retrospectively from March 2016 to February 2019, and diagnoses as made by the Neurologist were obtained. Data was analyzed using the Statistical Package for Social Sciences (SPSS) software (IBM SPSS statistics 21).Four hundred patients were seen out of which 49 of them had diagnosis of movement disorders made; giving a frequency of 12.3%. The mean age was 55 (SD = 13.49) years; 35 (71.4%) were males and 14 (28.6%) were females. Hypokinetic movement disorders were 28(57.1%) while hyperkinetic movement disorders were 21(42.9%). Twenty eight (57.2%) had Parkinsonism, 6 (12.2%) had dystonia, 6 (12.2%) had essential tremors, 4 (8.2%) had Tics, 3 (6.1%) had chorea and 2 (4.2%) had myoclonus. All the patients with Parkinsonism were on combination treatments namely: Levodopa/carbidopa with Trihexyphenidyl therapy 16 (57.1%) and Levodopa/carbidopa therapy 8 (28.6%). About 6 (50.0%) of dystonia cases were on clonazepam monotherapy; essential tremor, 9 (75.0%) of them were on propranolol monotherapy; tics, 3 (75.0%) of them were on haloperidol and all the 3 patients with chorea were on haloperidol. Parkinsonism is the most common movement disorder seen in our cohort.

Metrics

Metrics Loading ...

Article Details

How to Cite
1.
Iwuozo U, Enyikwola O, Mbaave T, Obiako O. A 3-Year Review of Frequency and Pattern of Movement Disorders in a Neurologic Clinic of a Tertiary Hospital in Nigeria. Wes J Med Biomed Sci [Internet]. 2022 Feb. 13 [cited 2024 May 16];3(1):89-95. Available from: https://wjmbs.com.ng/index.php/wjmbs/article/view/65
Section
Original Article

References

Akinyemi RO. Epidemiology of Parkinsonism and Parkinson's disease in Sub-Saharan Africa: Nigerian profile. J Neurosci Rural Pract. 2012; 3(3): 233–234.

Defazio G, Abbruzzese G, Livrea P, Berardelli A. Epidemiology of primary dystonia. Lancet Neurol. 2004;3(11):673-8. doi: 10.1016/S1474-4422(04)00907-X. PMID: 15488460.

Defazio G. The epidemiology of primary dystonia: current evidence and perspectives. Eur. J. Neurol. 2010; 17 Suppl. 1:9-14. https://doi.org/10.1111/j.1468-1331.2010.03053.x

Fahn S, Jankovic J, Hallett M. Principles and Practice of movement disorders. 2nd ed., New York: Saunders; 2011.

Nambu A. Pathophysiology of movement disorders. Rinsho Shinkeigaku. 2012;52 (11):1198-200. Japanese. doi: 10.5692/clinicalneurol.52.1198. PMID: 23196562.

Wilson FA, Bart PC, David JB, Niall PQ, Bastiaan RB. The Clinical Approach to Movement Disorders. Medscape.org/viewarticle/714547. Accessed 7/10/2021

Jankovic J. Treatment of Movement disorders. Neurologic clinics 2020; 38(2):13-14. (https://www.sciencedirect.com/science/article/pii/S0733861920300128)DOI: https://doi.org/10.1016/j.ncl.2020.03.001

Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry.1988;51:745–52. doi:10.1136/jnnp.51.6.745

Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30:1591–601. doi:10.1002/mds.26424.

Fernandez H, Schneider S.A. Essential tremor. Updated 2019. Movement disorders.org/MDS/Movement disorder overview/Tremor-Essential tremor. Accessed 7/10/2021.

National institute of Neurological disorders and stroke. Dystonia Factsheet, NINDS publication, updated 16/8/2021. Accessed 9/9/2021

Fernandez H, Christos G. Tics and Tourette syndrome. Updated 2019. Movement disorders.org/MDS/Movement disorder overview/Tics and Tourette syndrome. Accessed 9/9/2021.

Shu-Leong H, Esther C, Mark G, Brandon B. Chorea and Huntington’s disease. Movement disorders.org/MDS/Movement disorder overview/Chorea and Huntington’s disease. Accessed 9/9/2021.

Marcello M, Sterre Van der V. Movement disorders.org/MDS/Movement disorder overview/Myoclonus and Startle. Accessed 9/9/2021.

Molokwu O, Ezeala‐Adikaibe B, Onwuekwe I, Ekenze O Nwabueze AC. Frequency and pattern of Movement Disorders at a tertiary care hospital in Enugu, Southeast Nigeria. Movement Disorders. 2015; P1134:30.

Bower JH, Teshome M, Melaku Z, Zenebe G. Frequency of movement disorders in an Ethiopian university practice. Mov Disord. 2005; 20(9):1209-13. doi: 10.1002/mds.20567. PMID: 15954128

Okubadejo NU, Ojo OO, Oshinaike OO, Bankole IA, Aiyejusunle CB. Spectrum of movement disorders at the premier Lagos Movement Disorders Clinic in Nigeria: First year experience. Movement Disorders Conference: 16th International Congress of Parkinson's disease and movement disorder 2012; 27: S1-S523

Balestrassi LS, Silva SMCA. Descriptive epidemiological study on patients with movement disorders, with emphasis on Parkinson's disease. Sao Paulo Med J. 2021; 139 (1):30-37. doi: 10.1590/1516-3180.2020.0119.R1.30102020. PMID: 33656125

Bhidayasiri R, Saksornchai K, Kaewwilai L, Phanthumchinda K. A census of movement disorders at a Thai university hospital. J Neurol Sci. 2011; 301(1-2):31-4. doi: 10.1016/j.jns.2010.11.010. Epub 2010 Dec 4. PMID: 21131010.

Cilia R, Cereda E, Akpalu A, Sarfo FS, Cham M, Laryea R et al. Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa. Brain. 2020; 143(8):2490-2501. doi: 10.1093/brain/awaa181. PMID: 32844196; PMCID: PMC7566883.

David J.B, Angelo A. Parkinsonism, updated 2019. Movementdisorders.org/MDS/Movement disorder overview/Parkinsonism. Accessed 9/9/2021.

Termsarasab P, Thammongkolchai T, Frucht SJ. Medical treatment of dystonia. J Clin Mov Disord. 2016 Dec 19; 3:19. doi: 10.1186/s40734-016-0047-6. Erratum in: J Clin Mov Disord. 2018 Nov 16; 5:8. PMID: 28031858; PMCID: PMC5168853.

Zesiewicz TA, Elble RJ, Louis ED, Gronseth GS, Ondo WG, Dewey RB Jr et al Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology 2011;77(19):1752-5. doi: 10.1212/WNL.0b013e318236f0fd. Epub 2011 Oct 19. PMID: 22013182; PMCID: PMC3208950.

Pringsheim T, Okun MS, Müller-Vahl K, Martino D, Jankovic J, Cavanna AE et al. Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019; 92(19):896-906. doi: 10.1212/WNL.0000000000007466. PMID: 31061208; PMCID: PMC6537133.

Caviness JN. Treatment of myoclonus. Neurotherapeutics 2014;11(1):188-200. doi: 10.1007/s13311-013-0216-3. PMID: 24037428; PMCID: PMC3899494.

Caviness JN, Brown P. Myoclonus: current concepts and recent advances. Lancet Neurol. 2004; 3:598–607. doi: 10.1016/S1474-4422(04)00880-4.